1. Home
  2. CSBR vs BHST Comparison

CSBR vs BHST Comparison

Compare CSBR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • BHST
  • Stock Information
  • Founded
  • CSBR 1985
  • BHST 2007
  • Country
  • CSBR United States
  • BHST Canada
  • Employees
  • CSBR N/A
  • BHST N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • BHST
  • Sector
  • CSBR Health Care
  • BHST
  • Exchange
  • CSBR Nasdaq
  • BHST Nasdaq
  • Market Cap
  • CSBR 113.0M
  • BHST 106.0M
  • IPO Year
  • CSBR 1986
  • BHST N/A
  • Fundamental
  • Price
  • CSBR $6.21
  • BHST $6.44
  • Analyst Decision
  • CSBR Strong Buy
  • BHST Strong Buy
  • Analyst Count
  • CSBR 1
  • BHST 2
  • Target Price
  • CSBR $12.00
  • BHST $13.00
  • AVG Volume (30 Days)
  • CSBR 42.0K
  • BHST 43.5K
  • Earning Date
  • CSBR 03-11-2025
  • BHST 05-15-2025
  • Dividend Yield
  • CSBR N/A
  • BHST N/A
  • EPS Growth
  • CSBR N/A
  • BHST N/A
  • EPS
  • CSBR 0.46
  • BHST N/A
  • Revenue
  • CSBR $58,591,000.00
  • BHST $25,188,000.00
  • Revenue This Year
  • CSBR $15.11
  • BHST $116.40
  • Revenue Next Year
  • CSBR $7.80
  • BHST $55.91
  • P/E Ratio
  • CSBR $12.94
  • BHST N/A
  • Revenue Growth
  • CSBR 19.03
  • BHST 98.77
  • 52 Week Low
  • CSBR $3.60
  • BHST $0.00
  • 52 Week High
  • CSBR $11.99
  • BHST $7.38
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 36.72
  • BHST N/A
  • Support Level
  • CSBR $5.65
  • BHST N/A
  • Resistance Level
  • CSBR $8.27
  • BHST N/A
  • Average True Range (ATR)
  • CSBR 0.57
  • BHST 0.00
  • MACD
  • CSBR -0.08
  • BHST 0.00
  • Stochastic Oscillator
  • CSBR 21.67
  • BHST 0.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: